Astrazeneca (AZN) Stock Price
$74.22 0.5%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
9 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Astrazeneca, AI stock picks, stock alerts and much more.
AZN AI Stock Analysis
AI stock analysis for AZN is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Astrazeneca (AZN) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Astrazeneca (AZN) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Astrazeneca (AZN), currently trading at $74.22, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About AZN
-
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines.
-
Symbol
AZN
-
Market
NASDAQ
-
Industry
Drug Manufacturers - General
-
Market Cap
230.2B
Similar Stocks
 |
Amgen AMGN |
$300.9 1% |
5 |
 |
Gilead Sciences GILD |
$110.4 0.3% |
7 |
 |
Sanofi SNY |
$54.39 0.5% |
5 |
 |
Biogen BIIB |
$140.2 2.3% |
5 |
News
AZN Alternative Data
Web Traffic
Astrazeneca receives an estimated 820479 monthly visitors to astrazeneca.com.
-
Web Traffic
820479
-
Change from Previous Month
10.2%
-
3 Month Change
0.2%
-
YoY Change
0.2%
News Mentions
Astrazeneca was mentioned 4 times in the news yesterday.
-
News Mentions
4
-
Daily Change
33.3%
-
1 Month Change
42.9%
-
3 Month Change
73.3%
Reddit Mentions
Astrazeneca has been mentioned an estimated 2 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
2
-
Daily Change
0%
Twitter Followers
Astrazeneca has 297,930 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.4% over the last month.
-
Twitter Followers
297930
-
Daily Change
0%
-
1 Month Change
0.4%
-
3 Month Change
0.7%
-
YoY Change
0.7%
Facebook Engagement
Astrazeneca has engaged 110 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
110
-
Daily Change
2.7%
-
1 Month Change
24.1%
-
3 Month Change
29.9%
-
YoY Change
29.9%
Instagram Followers
Astrazeneca has 80,169 Instagram Followers on its main Instagram account, up by 1.3% over the last month.
-
Instagram Followers
80169
-
Daily Change
0%
-
1 Month Change
1.3%
-
3 Month Change
2.9%
-
YoY Change
2.9%
Youtube Subscribers
Astrazeneca has 17,700 subscribers on its main Youtube channel, up by 0.6% over the last month.
-
Youtube Subscribers
17700
-
Daily Change
0%
-
1 Month Change
0.6%
-
3 Month Change
7.3%
-
YoY Change
7.3%
LinkedIn Followers
3,133,607 are following Astrazeneca on LinkedIn, up by 1.2% over the last month.
-
LinkedIn Followers
3133607
-
Daily Change
0%
-
1 Month Change
1.2%
-
3 Month Change
2.7%
Job Postings
Astrazeneca currenly has an estimated 1,000 open job postings.
-
Job Postings
1000
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, Astrazeneca has 76,212 employees, up by 0.5% over the last month.
-
LinkedIn Employees
76212
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
3.4%
-
YoY Change
3.4%
Business Outlook
-
Business Outlook
82
-
Change from Previous Month
1.2%
-
3 Month Change
0%
-
YoY Change
0%
AZN Financials
AZN Key Metrics
-
Total Revenue
$13.6B
-
Net Income
$1.4B
-
Earnings per Share
$0.46
-
Free cash flow
$2B
-
EBITDA
$4.1B
-
EBITDA Ratio
0.302396
-
Total Assets
$104.9B
AZN 2-year Revenue & Income
AZN 2-year Free Cash Flow
AZN Technicals
AZN SMA
AZN RSI
FAQ
What's the current price of Astrazeneca (AZN) Stock?
The price of an Astrazeneca (AZN) share is $74.22.
What's the market cap of Astrazeneca?
The current market cap of Astrazeneca is 230.2B.
Should I buy or sell AZN?
Multiple alternative data signals suggest that Astrazeneca stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.
Is Astrazeneca a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Astrazeneca stock. The bullish indicators suggest that Astrazeneca's growth prospects and market position may lead to a positive performance in the foreseeable future.
Is now a good time to buy Astrazeneca (AZN) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Astrazeneca stock, given the bullish outlook.
What are some stocks similar to Astrazeneca (AZN) that investors often compare it to?
Astrazeneca (AZN) is often compared to similar stocks such as Amgen, Gilead Sciences, Sanofi and Biogen.
What is the forecast for Astrazeneca's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Astrazeneca's stock price to be around $80.54 in 2026. Starting from the current price of $74.22, this represents a 8.5% change in price, indicating a bullish outlook for the stock.
How to buy Astrazeneca (AZN) Stock?
Astrazeneca stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Astrazeneca shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.